| Supplier |
Ace Therapeutics |
| Product # |
NSC684 |
| Pricing |
Inquiry
|
| Product Size |
100 µg
|
| Purity |
≥ 95 % as determined by SDS-PAGE. ≥ 90 % as determined by SEC-HPLC.
|
| Product Type |
Proteins
|
| Synonyms |
NACP Protein, Human; PARK1 Protein, Human; PARK4 Protein, Human; PD1 Protein, Human
|
| Endotoxin |
< 1.0 EU per μg protein as determined by the LAL method.
|
| Activity |
Testing in progress
|
| Protein Construction |
A DNA sequence encoding the human SNCA (P37840-1) (H50Q, Met1-Ala140) was expressed.
|
| Accession# |
P37840-1
|
| Expressed Host |
E. coli
|
| Species |
Human
|
| Predicted N Terminal |
Met 1
|
| Molecule Mass |
The recombinant human SNCA consists of 140 amino acids and predicts a molecular mass of 14.45 kDa.
|
| Formulation |
Lyophilized from sterile PBS 2mM TCEP, pH 7.4.Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
|
| Shipping |
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
|
| Stability & Storage |
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| Reconstitution |
A hardcopy of datasheet with reconstitution instructions is sent along with the products. Please refer to it for detailed information.
|